1. Home
  2. SERA vs SRG Comparison

SERA vs SRG Comparison

Compare SERA & SRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SERA
  • SRG
  • Stock Information
  • Founded
  • SERA 2008
  • SRG 2014
  • Country
  • SERA United States
  • SRG United States
  • Employees
  • SERA N/A
  • SRG N/A
  • Industry
  • SERA Precision Instruments
  • SRG Real Estate Investment Trusts
  • Sector
  • SERA Health Care
  • SRG Real Estate
  • Exchange
  • SERA Nasdaq
  • SRG Nasdaq
  • Market Cap
  • SERA 70.4M
  • SRG 163.3M
  • IPO Year
  • SERA 2021
  • SRG 2015
  • Fundamental
  • Price
  • SERA $2.75
  • SRG $3.03
  • Analyst Decision
  • SERA
  • SRG
  • Analyst Count
  • SERA 0
  • SRG 0
  • Target Price
  • SERA N/A
  • SRG N/A
  • AVG Volume (30 Days)
  • SERA 830.2K
  • SRG 95.3K
  • Earning Date
  • SERA 08-06-2025
  • SRG 08-13-2025
  • Dividend Yield
  • SERA N/A
  • SRG N/A
  • EPS Growth
  • SERA N/A
  • SRG N/A
  • EPS
  • SERA N/A
  • SRG N/A
  • Revenue
  • SERA $115,000.00
  • SRG N/A
  • Revenue This Year
  • SERA $390.13
  • SRG N/A
  • Revenue Next Year
  • SERA $440.54
  • SRG N/A
  • P/E Ratio
  • SERA N/A
  • SRG N/A
  • Revenue Growth
  • SERA N/A
  • SRG N/A
  • 52 Week Low
  • SERA $1.37
  • SRG $2.43
  • 52 Week High
  • SERA $9.13
  • SRG $5.52
  • Technical
  • Relative Strength Index (RSI)
  • SERA 57.15
  • SRG 54.43
  • Support Level
  • SERA $2.34
  • SRG $2.94
  • Resistance Level
  • SERA $4.09
  • SRG $3.18
  • Average True Range (ATR)
  • SERA 0.37
  • SRG 0.12
  • MACD
  • SERA 0.07
  • SRG -0.00
  • Stochastic Oscillator
  • SERA 41.36
  • SRG 57.73

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

About SRG Seritage Growth Properties

Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management, and leasing of diversified and mixed-use properties throughout the United States.

Share on Social Networks: